Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis

被引:83
作者
Sata, Masataka [1 ]
Fukuda, Daiju
机构
[1] Univ Tokushima, Inst Hlth Biosci, Grad Sch, Dept Cardiovasc Med, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan
关键词
atherosclerosis; renin-angiotensin system; reactive oxygen species; inflammation;
D O I
10.2152/jmi.57.12
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The renin-angiotensin system (RAS) has been demonstrated to play a critical role in the initiation and progression of atherosclerosis, thereby contributing to development of cardiovascular diseases. Angiotensin II (Ang II), a major substrate in RAS, stimulates atherosclerosis through various deleterious effects such as endothelial dysfunction, cellular proliferation and inflammation. Recently, local RAS in vasculature is reported to play an important role. Many of these atherogenic actions of Ang II are mediated by reactive oxygen species (ROS). Investigation of the role of ROS and inflammation induced by RAS may provide a clue to understanding the pathophysiology of atherosclerotic diseases, and may lead to a new therapeutic strategy.
引用
收藏
页码:12 / 25
页数:14
相关论文
共 144 条
[1]  
Abali Huseyin, 2002, Hematology, V7, P75, DOI 10.1080/10245330290022160
[2]   Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis [J].
Arakawa, K ;
Urata, H .
HYPERTENSION, 2000, 36 (04) :638-641
[3]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[4]   Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization [J].
Asahara, T ;
Masuda, H ;
Takahashi, T ;
Kalka, C ;
Pastore, C ;
Silver, M ;
Kearne, M ;
Magner, M ;
Isner, JM .
CIRCULATION RESEARCH, 1999, 85 (03) :221-228
[5]   Stimulation of endothelial progenitor cells - A new putative therapeutic effect of angiotensin II receptor antagonists [J].
Bahlmann, FH ;
de Groot, K ;
Mueller, O ;
Hertel, B ;
Haller, H ;
Fliser, D .
HYPERTENSION, 2005, 45 (04) :526-529
[6]   Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy [J].
Barnett, AH ;
Bain, SC ;
Bouter, P ;
Karlberg, B ;
Madsbad, S ;
Jervell, J ;
Mustonen, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (19) :1952-1961
[7]  
Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI200111927
[8]   Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s) [J].
Batenburg, WW ;
Tom, B ;
Schuijt, MP ;
Danser, AHJ .
VASCULAR PHARMACOLOGY, 2005, 42 (03) :109-118
[9]   The biology of restenosis [J].
Bauters, C ;
Isner, JM .
PROGRESS IN CARDIOVASCULAR DISEASES, 1997, 40 (02) :107-116
[10]   Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-κB (NF-κB) transcription factor [J].
Brasier, AR ;
Jamaluddin, M ;
Han, YQ ;
Patterson, C ;
Runge, MS .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2000, 212 (1-2) :155-169